Thyrocare Technologies informs about analyst meet

01 Dec 2018 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that Anand Velumani, Director of the wholly owned subsidiary, Nueclear Healthcare, and Aditya Shinde, Deputy General Manager- Finance would be participating at B & Ks Investor Conference- Emergent India- 2018 organized by Batlivala & Karani Securities India, at Hotel Trident BKC, Mumbai, on Wednesday, 5th December 2018, where the representatives of various Funds would be meeting, from 10.00 A.M to 6.00 P.M.

The above information is a part of company’s filings submitted to BSE.

 

 

Thyrocare Tech. Share Price

922.20 -26.85 (-2.83%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7000.00
Max Healthcare Inst 1008.35
Narayana Hrudayalay 1265.30
Aster DM Healthcare 442.70
Global Health 1105.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.